Autopsy report · NCT02417870
Ultra-low Dose Subcutaneous IL-2 in Renal Transplantation
Cause of deathFunding or business, also staffing, sites or logistics
“lack of funding/resources”
Life of this trial
- Registered 5 months before it started.
- Ran for about 2 years 7 months before it stopped.
- 2 participants enrolled.
- Results were posted on the registry 3 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- Anil K. Chandraker, MD
- Sponsor type
- University, hospital or other
- Conditions
- Kidney Transplantation
- Interventions
- aldesleukin
- Participants
- 2
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults
“Lack of funding”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.